Onconetix Inc

Research Onconetix Inc (ONCO) on Bullrun: market cap USD 1.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerONCO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.09M
• Financial periodFY2025
• RevenueUSD 815.37K
• Revenue growth-67.7%
• Net income-USD 14.03M
• Gross margin77.6%

Valuation Snapshot

latest market cap is USD 1.09M.

About Onconetix Inc

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test.

Frequently asked questions

What is Onconetix Inc's market cap?

Onconetix Inc's market capitalization is USD 1.09M.

What does Onconetix Inc do?

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union.